Skip to content
10-Q

Quarterly Report

PEPPERLIME HEALTH ACQUISITION CORPORATION

0001104659-23-060746

← back to feed
Filed
May 15, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Stock Repurchased Q1 2023 · Mar 31, 2023 $161.51M
Stock Repurchased Q1 2023 · Mar 31, 2022 $0
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$268.62K
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$105.19K
Cash And Equivalents Q1 2023 · Mar 31, 2023 $622.54K
Stockholders Equity Q1 2023 · Mar 31, 2023 −$5.86M
Stockholders Equity Q1 2023 · Dec 31, 2022 −$5.4M
Stockholders Equity Q1 2023 · Mar 31, 2022 −$4.37M
Stockholders Equity Q1 2023 · Dec 31, 2021 −$4.04M
Current Liabilities Q1 2023 · Mar 31, 2023 $844.33K
Current Liabilities Q1 2023 · Dec 31, 2022 $703.79K
Total Liabilities Q1 2023 · Mar 31, 2023 $6.79M
Total Liabilities Q1 2023 · Dec 31, 2022 $6.65M
Current Assets Q1 2023 · Mar 31, 2023 $932.16K
Current Assets Q1 2023 · Dec 31, 2022 $1.26M
Total Assets Q1 2023 · Mar 31, 2023 $14.02M
Total Assets Q1 2023 · Dec 31, 2022 $175.4M
Sga Expense Q1 2023 · Mar 31, 2023 $463.41K
Sga Expense Q1 2023 · Mar 31, 2022 $335.75K
Net Income Q1 2023 · Mar 31, 2023 −$8.24K
Net Income Q1 2023 · Mar 31, 2022 −$331.4K
Operating Income Q1 2023 · Mar 31, 2023 −$463.41K
Operating Income Q1 2023 · Mar 31, 2022 −$335.75K